Yayın:
The impact of TFPI on coronary atherosclerotic burden

dc.contributor.authorKahraman, S.
dc.contributor.authorErdim, R.
dc.contributor.authorHelvacioglu, F.
dc.contributor.authorDogan, A.
dc.contributor.authorSozer, V
dc.contributor.authorGunay, D.
dc.contributor.authorAytekin, S.
dc.contributor.authorAytekin, V
dc.date.accessioned2026-06-27T14:15:10Z
dc.date.issued2018
dc.description.abstractOBJECTIVES: We aimed to associate a coronary artery disease (CAD) presence and severity with endothelial dysfunction (ED), carotid intima media thickness (CIMT) and Tissue Factor Pathway Inhibitor (TFPI). BACKGROUND: ED has a central role in atherosclerosis. CIMT and TFPI activity are also related with atherosclerosis and CAD. METHODS: In our prospective observational study, 50 patients had CAD and 30 had normal coronary arteries. Endothelial function was evaluated by endothelium-dependent flow-mediated dilatation (FMD) and nitroglycerinemediated dilatation (NMD) measurements. CIMT and Serum TFPI levels were also measured. RESULTS: TFPI was a statistically significant determinant between the two groups with an increased level in CAD (+) group (84.9 +/- 19.3 vs 70.2 +/- 14.7, p = 0.001). There was a positive correlation between CIMT and Gensini (r = 0.34, p = 0.014). There was a strong negative correlation between Gensini and FMD-NMD, statistically significant (FMD: r =-0.715, p < 0.001; NMD: r = -0.718, p < 0.001). CONCLUSION: We observed that ED, increased CIMT and TFPI levels were associated with CAD. Additionally, increased CIMT measurements and decreased FMD and NMD values had a positive correlation with GSS (Tab. 4, Fig. 6, Ref. 50). Text in PDF www.elis.sk.en
dc.description.urihttps://doi.org/10.4149/bll_2018_071
dc.identifier.doi10.4149/bll_2018_071
dc.identifier.eissn1336-0345
dc.identifier.endpage390
dc.identifier.issn0006-9248
dc.identifier.issue6
dc.identifier.pubmed29947240
dc.identifier.startpage385
dc.identifier.urihttps://hdl.handle.net/20.500.14981/58474
dc.identifier.volume119
dc.identifier.wos000436626500011
dc.language.isoeng
dc.publisherCOMENIUS UNIV
dc.relation.ispartofBRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
dc.rightsopenAccess
dc.subjectcoronary artery disease
dc.subjectendothelial dysfunction
dc.subjecttissue factor pathway inhibitor
dc.subjectFACTOR PATHWAY INHIBITOR
dc.subjectFLOW-MEDIATED VASODILATION
dc.subjectTISSUE FACTOR
dc.subjectHEART-DISEASE
dc.subjectARTERY-DISEASE
dc.subjectBRACHIAL-ARTERY
dc.subjectPROGNOSTIC VALUE
dc.subjectSMOOTH-MUSCLE
dc.subjectRISK-FACTORS
dc.subjectGeneral & Internal Medicine
dc.titleThe impact of TFPI on coronary atherosclerotic burden
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar